{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:56:18Z","timestamp":1781643378744,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100016003","name":"Istanbul University Cerrahpa\u015fa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100016003","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cerebrotendinous xanthomatosis (CTX) is a rare, treatable bile acid synthesis disorder characterized by increased levels of cholestanol. Studies indicate that autism spectrum disorder (ASD) may be an early manifestation of CTX. Independent of CTX, disturbances in sterol and bile acid metabolism are observed in ASD. Therefore, this study aimed to estimate the prevalence of CTX in a pediatric ASD cohort using cholestanol-based screening with reflex\n                    <jats:italic>CYP27A1<\/jats:italic>\n                    sequencing and to compare plasma sterol profiles among children with ASD. We conducted a single-center, cross-sectional study including 103 patients with ASD and 70 age-matched, normally developed children. Fasting plasma cholestanol, campesterol, stigmasterol and sitosterol were quantified by gas chromatography\/mass spectrometry. Participants with cholestanol\u2009\u2265\u20097\u00a0\u00b5g\/ml underwent\n                    <jats:italic>CYP27A1<\/jats:italic>\n                    sequencing, and five-day dietary recalls were analyzed in 75 ASD participants. Elevated cholestanol was observed in 27 of 103 patients with ASD (26.2%) but in none of the controls (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). No participant had biallelic pathogenic\n                    <jats:italic>CYP27A1<\/jats:italic>\n                    variants; one heterozygous variant of uncertain significance was detected. Median concentrations of cholestanol, campesterol, sitosterol and stigmasterol were significantly higher in patients with ASD than in controls (all\n                    <jats:italic>p<\/jats:italic>\n                    \u2009\u2264\u20090.001), and sterol fractions were strongly correlated (cholestanol\u2013campesterol\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.74,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). In summary, no cases of CTX were identified in this cohort, suggesting that cholestanol-based screening in unselected ASD populations may have limited yield, particularly in the absence of additional clinical features suggestive of CTX. Nevertheless, the elevated plasma sterol levels in ASD patients suggest dysregulated sterol and bile acid homeostasis, warranting further investigation.\n                  <\/jats:p>","DOI":"10.1007\/s11011-026-01827-7","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:29:57Z","timestamp":1773818997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma sterol profiling in autism spectrum disorder: insights from cerebrotendinous xanthomatosis screening and beyond"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8645-5975","authenticated-orcid":false,"given":"Kagan","family":"Calisgan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7159-4008","authenticated-orcid":false,"given":"Tanyel","family":"Zubarioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7487-1376","authenticated-orcid":false,"given":"Esra","family":"\u0130sat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0734-4415","authenticated-orcid":false,"given":"Hanim","family":"Babazade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9363-048X","authenticated-orcid":false,"given":"Sedanur","family":"Akca-Yesil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9948-0419","authenticated-orcid":false,"given":"Selin","family":"Akbulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0457-088X","authenticated-orcid":false,"given":"Esma","family":"Uygur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8907-5135","authenticated-orcid":false,"given":"Vildan","family":"Keskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9994-7250","authenticated-orcid":false,"given":"Busra","family":"Cirkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7863-4551","authenticated-orcid":false,"given":"Gizem","family":"Durcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6276-8179","authenticated-orcid":false,"given":"Burak","family":"Dogangun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3315-5124","authenticated-orcid":false,"given":"Mehmet Serif","family":"Cansever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7256-0750","authenticated-orcid":false,"given":"Ayse Cigdem","family":"Aktuglu-Zeybek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5170-5594","authenticated-orcid":false,"given":"Ertugrul","family":"Kiykim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"1827_CR45","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jaapos.2021.04.015","volume":"25","author":"T AtillaH, Coskun","year":"2021","unstructured":"AtillaH,Coskun T, Elibol B et al (2021) Prevalence of cerebrotendinous xanthomatosis in cases with idiopathic bilateral juvenile cataract in ophthalmology clinics in Turkey. J Am Assoc Pediatr Ophthalmol Strabismus 25:269. https:\/\/doi.org\/10.1016\/j.jaapos.2021.04.015","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"1827_CR2","doi-asserted-by":"publisher","first-page":"6483","DOI":"10.3390\/ijms26136483","volume":"26","author":"G Ayoub","year":"2025","unstructured":"Ayoub G (2025) Autism Spectrum Disorder as a Multifactorial Disorder: the interplay of genetic factors and inflammation. Int J Mol Sci 26:6483. https:\/\/doi.org\/10.3390\/ijms26136483","journal-title":"Int J Mol Sci"},{"key":"1827_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/17549507.2013.858773","volume":"16","author":"S Camarata","year":"2014","unstructured":"Camarata S (2014) Early identification and early intervention in autism spectrum disorders: accurate and effective? Int J Speech Lang Pathol 16:1\u201310. https:\/\/doi.org\/10.3109\/17549507.2013.858773","journal-title":"Int J Speech Lang Pathol"},{"key":"1827_CR4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/cbf.3811","volume":"41","author":"C Cao","year":"2023","unstructured":"Cao C, Wang D, Zou M et al (2023) Untargeted metabolomics reveals hepatic metabolic disorder in the BTBR mouse model of autism and the significant role of liver in autism. Cell Biochem Funct 41:553\u2013563. https:\/\/doi.org\/10.1002\/cbf.3811","journal-title":"Cell Biochem Funct"},{"key":"1827_CR5","doi-asserted-by":"publisher","first-page":"e1004331","DOI":"10.1371\/journal.pmed.1004331","volume":"21","author":"S Chen","year":"2024","unstructured":"Chen S, Ahlqvist VH, Sj\u00f6qvist H et al (2024) Maternal intrahepatic cholestasis of pregnancy and neurodevelopmental conditions in offspring: A population-based cohort study of 2 million Swedish children. PLOS Med 21:e1004331. https:\/\/doi.org\/10.1371\/journal.pmed.1004331","journal-title":"PLOS Med"},{"key":"1827_CR6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10545-008-0963-1","volume":"31","author":"MGM de Sain-van der Velden","year":"2008","unstructured":"de Sain-van der Velden MGM, Verrips A, Prinsen BHCMT et al (2008) Elevated cholesterol precursors other than cholestanol can also be a hallmark for CTX. J Inherit Metab Dis 31:387\u2013393. https:\/\/doi.org\/10.1007\/s10545-008-0963-1","journal-title":"J Inherit Metab Dis"},{"key":"1827_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40291-019-00430-0","volume":"24","author":"A El-Ansary","year":"2020","unstructured":"El-Ansary A, Chirumbolo S, Bhat RS et al (2020) The role of lipidomics in autism spectrum disorder. Mol Diagn Ther 24:31\u201348. https:\/\/doi.org\/10.1007\/s40291-019-00430-0","journal-title":"Mol Diagn Ther"},{"key":"1827_CR8","volume-title":"GeneReviews\u00ae","author":"A Federico","year":"1993","unstructured":"Federico A, Gallus GN (1993) Cerebrotendinous xanthomatosis. In: Adam MP, Feldman J, Mirzaa GM et al (eds) GeneReviews\u00ae. University of Washington, Seattle, Seattle (WA)"},{"key":"1827_CR9","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/s13023-022-02591-4","volume":"17","author":"G Fern\u00e1ndez-Eulate","year":"2022","unstructured":"Fern\u00e1ndez-Eulate G, Martin GC, Dureau P et al (2022) Prospective cholestanol screening of cerebrotendinous xanthomatosis among patients with juvenile-onset unexplained bilateral cataracts. Orphanet J Rare Dis 17:434. https:\/\/doi.org\/10.1007\/s40291-019-00430-0","journal-title":"Orphanet J Rare Dis"},{"key":"1827_CR10","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1001\/jamaophthalmol.2019.3639","volume":"137","author":"SF Freedman","year":"2019","unstructured":"Freedman SF, Brennand C, Chiang J et al (2019) Prevalence of cerebrotendinous xanthomatosis among patients diagnosed with acquired juvenile-onset idiopathic bilateral cataracts. JAMA Ophthalmol 137:1312. https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.3639","journal-title":"JAMA Ophthalmol"},{"key":"1827_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jaapos.2023.04.013","volume":"27","author":"SF Freedman","year":"2023","unstructured":"Freedman SF, Del Monte MA, Diva U et al (2023) Prevalence of cerebrotendinous xanthomatosis among patients diagnosed with early-onset idiopathic bilateral cataracts: final analysis. J Am Assoc Pediatr Ophthalmol Strabismus 27:208\u2013211. https:\/\/doi.org\/10.1016\/j.jaapos.2023.04.013","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"1827_CR12","doi-asserted-by":"crossref","unstructured":"Harm M, Hope M, Household A (2013) American psychiatric association, 2013, diagnostic and statistical manual of mental disorders, 5th edn, washington, dc: American psychiatric association. In: Anderson J, Sapey B, Spandler H (eds.), 2012, distress or disability? lancaster: Centre for disability research. Arya 347:64","DOI":"10.1176\/appi.books.9780890425596"},{"key":"1827_CR13","doi-asserted-by":"publisher","first-page":"337ra63","DOI":"10.1126\/scitranslmed.aaf2326","volume":"8","author":"X Jiang","year":"2016","unstructured":"Jiang X, Sidhu R, Mydock-McGrane L et al (2016) Development of a bile acid\u2013based newborn screen for Niemann-Pick disease type C. Sci Transl Med 8:337ra63\u2013337ra63. https:\/\/doi.org\/10.1126\/scitranslmed.aaf2326","journal-title":"Sci Transl Med"},{"key":"1827_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1517\/14712598.2014.880420","volume":"14","author":"ML Jones","year":"2014","unstructured":"Jones ML, Martoni,Christopher J, Ganopolsky, Jorge G et al (2014) The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention. Expert Opin Biol Ther 14:467\u2013482. https:\/\/doi.org\/10.1517\/14712598.2014.880420","journal-title":"Expert Opin Biol Ther"},{"key":"1827_CR15","doi-asserted-by":"publisher","unstructured":"Karadag M, Turan MI, Celebi C, Caglar T (2025) )(Cerebrotendinous xanthomatosis disease prevalence in patients with autism spectrum disorder: a prospective observational study. Mol Syndromol 16:1\u201312. https:\/\/doi.org\/10.1159\/000542453","DOI":"10.1159\/000542453"},{"key":"1827_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/aur.1507","volume":"9","author":"E Kiykim","year":"2016","unstructured":"Kiykim E, Zeybek CA, Zubarioglu T et al (2016) Inherited metabolic disorders in Turkish patients with autism spectrum disorders. Autism Res 9:217\u2013223. https:\/\/doi.org\/10.1002\/aur.1507","journal-title":"Autism Res"},{"key":"1827_CR17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3343\/alm.2019.39.4.411","volume":"39","author":"JH Lee","year":"2019","unstructured":"Lee JH, Lee K, Jun S-H et al (2019) A multiplex phytosterol assay utilizing gas chromatography-mass spectrometry for diagnosis of inherited lipid storage disorders. Ann Lab Med 39:411\u2013413. https:\/\/doi.org\/10.3343\/alm.2019.39.4.411","journal-title":"Ann Lab Med"},{"key":"1827_CR18","doi-asserted-by":"publisher","first-page":"e12809","DOI":"10.1002\/jimd.12809","volume":"48","author":"T Lefebvre","year":"2025","unstructured":"Lefebvre T, Eguether T, Th\u00e9venot E et al (2025) Nontargeted urine metabolomic analysis of acute intermittent porphyria reveals novel interactions between bile acids and heme metabolism: new promising biomarkers for the long-term management of patients. J Inherit Metab Dis 48:e12809. https:\/\/doi.org\/10.1002\/jimd.12809","journal-title":"J Inherit Metab Dis"},{"key":"1827_CR19","first-page":"907","volume":"55","author":"E Leitersdorf","year":"1994","unstructured":"Leitersdorf E, Safadi R, Meiner V et al (1994) Cerebrotendinous xanthomatosis in the Israeli Druze: molecular genetics and phenotypic characteristics. Am J Hum Genet 55:907","journal-title":"Am J Hum Genet"},{"key":"1827_CR20","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10545-013-9674-3","volume":"37","author":"A Mignarri","year":"2014","unstructured":"Mignarri A, Gallus GN, Dotti MT, Federico A (2014) A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis. J Inherit Metab Dis 37:421\u2013429. https:\/\/doi.org\/10.1007\/s10545-013-9674-3","journal-title":"J Inherit Metab Dis"},{"key":"1827_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10545-015-9873-1","volume":"39","author":"A Mignarri","year":"2016","unstructured":"Mignarri A, Magni A, Del Puppo M et al (2016) Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis. J Inherit Metab Dis 39:75\u201383. https:\/\/doi.org\/10.1007\/s10545-015-9873-1","journal-title":"J Inherit Metab Dis"},{"key":"1827_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13023-014-0179-4","volume":"9","author":"S Nie","year":"2014","unstructured":"Nie S, Chen G, Cao X, Zhang Y (2014) Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management. Orphanet J Rare Dis 9:179. https:\/\/doi.org\/10.1186\/s13023-014-0179-4","journal-title":"Orphanet J Rare Dis"},{"key":"1827_CR23","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1007\/s11011-023-01287-3","volume":"38","author":"E Oge-Enver","year":"2023","unstructured":"Oge-Enver E, Isat E, Cansever MS et al (2023) Urinary neopterin and biopterin indicate that inflammation has a role in autism spectrum disorder. Metab Brain Dis 38:2645\u20132651. https:\/\/doi.org\/10.1007\/s11011-023-01287-3","journal-title":"Metab Brain Dis"},{"key":"1827_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5607\/en.2016.25.1.1","volume":"25","author":"HR Park","year":"2016","unstructured":"Park HR, Lee JM, Moon HE et al (2016) A short review on the current understanding of autism spectrum disorders. Exp Neurobiol 25:1\u201313. https:\/\/doi.org\/10.5607\/en.2016.25.1.1","journal-title":"Exp Neurobiol"},{"key":"1827_CR25","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.jhep.2010.12.004","volume":"54","author":"TWH Pols","year":"2011","unstructured":"Pols TWH, Noriega LG, Nomura M et al (2011) The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. J Hepatol 54:1263\u20131272. https:\/\/doi.org\/10.1016\/j.jhep.2010.12.004","journal-title":"J Hepatol"},{"key":"1827_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/978-3-030-05542-4_13","volume-title":"Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders","author":"J Pulikkan","year":"2019","unstructured":"Pulikkan J, Mazumder A, Grace T (2019) Role of the gut microbiome in autism spectrum disorders. In: Guest PC (ed) Reviews on biomarker studies in psychiatric and neurodegenerative disorders. Springer international publishing, Cham, pp 253\u2013269"},{"key":"1827_CR27","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/aur.2311","volume":"13","author":"B Ritz","year":"2020","unstructured":"Ritz B, Yan Q, Uppal K et al (2020) Untargeted metabolomics screen of mid-pregnancy maternal serum and autism in offspring. Autism Res 13:1258\u20131269. https:\/\/doi.org\/10.1002\/aur.2311","journal-title":"Autism Res"},{"key":"1827_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","volume":"72","author":"DW Russell","year":"2003","unstructured":"Russell DW (2003) The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 72:137\u2013174. https:\/\/doi.org\/10.1146\/annurev.biochem.72.121801.161712","journal-title":"Annu Rev Biochem"},{"key":"1827_CR29","doi-asserted-by":"publisher","first-page":"843","DOI":"10.7326\/0003-4819-75-6-843","volume":"75","author":"G Salen","year":"1971","unstructured":"Salen G (1971) Cholestanol deposition in cerebrotendinous xanthomatosis: a possible mechanism. Ann Intern Med 75:843\u2013851. https:\/\/doi.org\/10.7326\/0003-4819-75-6-843","journal-title":"Ann Intern Med"},{"key":"1827_CR30","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3390\/genes14040803","volume":"14","author":"UD Senarathne","year":"2023","unstructured":"Senarathne UD, Indika N-LR, Jezela-Stanek A et al (2023) Biochemical, genetic and clinical diagnostic approaches to autism-associated inherited metabolic disorders. Genes 14:803. https:\/\/doi.org\/10.3390\/genes14040803","journal-title":"Genes"},{"key":"1827_CR31","doi-asserted-by":"publisher","unstructured":"Shaw KA (2025) Prevalence and early identification of autism spectrum disorder among children aged 4 and 8 years \u2014 autism and developmental disabilities monitoring network, 16 sites, United States, 2022, MMWR Surveill Summ 74. https:\/\/doi.org\/10.15585\/mmwr.ss7402a1","DOI":"10.15585\/mmwr.ss7402a1"},{"key":"1827_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/clipsy.6.1.33","volume":"6","author":"DM Sikora","year":"2006","unstructured":"Sikora DM, Pettit-Kekel K, Penfield J, Merkens LS, Steiner RD (2006) The near universal presence of autism spectrum disorders in children with Smith\u2013Lemli\u2013Opitz Smith T (1999) Outcome of early intervention for children with autism. Clin Psychol Sci Pract 6:33\u201349. https:\/\/doi.org\/10.1093\/clipsy.6.1.33","journal-title":"Clin Psychol Sci Pract"},{"key":"1827_CR44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/clipsy.6.1.33","volume":"6","author":"T Smith","year":"1999","unstructured":"SmithT (1999) Outcome of Early Intervention for Children With Autism. Clin Psychol Sci Pract 6:33\u201349. https:\/\/doi.org\/10.1093\/clipsy.6.1.33","journal-title":"Clin Psychol Sci Pract"},{"key":"1827_CR33","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s10545-017-0086-7","volume":"41","author":"BML Stelten","year":"2018","unstructured":"Stelten BML, Bonnot O, Huidekoper HH et al (2018) Autism spectrum disorder: an early and frequent feature in cerebrotendinous xanthomatosis. J Inherit Metab Dis 41:641\u2013646. https:\/\/doi.org\/10.1007\/s10545-017-0086-7","journal-title":"J Inherit Metab Dis"},{"key":"1827_CR35","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1212\/WNL.0000000000006731","volume":"92","author":"BML Stelten","year":"2019","unstructured":"Stelten BML, Huidekoper HH, van de Warrenburg BPC et al (2019) Long-term treatment effect in cerebrotendinous xanthomatosis depends on age at treatment start. Neurology 92:e83\u2013e95. https:\/\/doi.org\/10.1212\/WNL.0000000000006731","journal-title":"Neurology"},{"key":"1827_CR34","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s13023-021-01980-5","volume":"16","author":"BML Stelten","year":"2021","unstructured":"Stelten BML, Dotti MT, Verrips A et al (2021) Expert opinion on diagnosing, treating and managing patients with cerebrotendinous xanthomatosis (CTX): a modified Delphi study. Orphanet J Rare Dis 16:353. https:\/\/doi.org\/10.1186\/s13023-021-01980-5","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"1827_CR36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/ajmg.c.31347","volume":"160C","author":"MD Svoboda","year":"2012","unstructured":"Svoboda MD, Christie JM, Eroglu Y, Freeman KA, Steiner RD (2012) Treatment of Smith\u2013Lemli\u2013Opitz syndrome and other sterol disorders. Am J Med Genet Part C: Seminars Med Genet 160 C(4):285\u2013294. https:\/\/doi.org\/10.1002\/ajmg.c.31347","journal-title":"Am J Med Genet Part C: Seminars Med Genet"},{"issue":"1","key":"1827_CR37","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41398-021-01580-8","volume":"11","author":"E Tierney","year":"2021","unstructured":"Tierney E, Remaley AT, Thurm A, Jager LR, Wassif CA, Kratz LE, Bailey-Wilson JE, Bukelis I, Sarphare G, Jung ES, Brand B, Noah KK, Porter FD (2021) Sterol and lipid analyses identifies hypolipidemia and apolipoprotein disorders in autism associated with adaptive functioning deficits. Translational Psychiatry 11(1):471. https:\/\/doi.org\/10.1038\/s41398-021-01580-8","journal-title":"Translational Psychiatry"},{"key":"1827_CR38","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s10072-019-04169-8","volume":"41","author":"A Verrips","year":"2020","unstructured":"Verrips A, Dotti MT, Mignarri A et al (2020) The safety and effectiveness of chenodeoxycholic acid treatment in patients with cerebrotendinous xanthomatosis: two retrospective cohort studies. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 41:943\u2013949. https:\/\/doi.org\/10.1007\/s10072-019-04169-8","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"key":"1827_CR39","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10545-018-0152-9","volume":"41","author":"JC Wong","year":"2018","unstructured":"Wong JC, Walsh K, Hayden D, Eichler FS (2018) Natural history of neurological abnormalities in cerebrotendinous xanthomatosis. J Inherit Metab Dis 41:647\u2013656. https:\/\/doi.org\/10.1007\/s10545-018-0152-9","journal-title":"J Inherit Metab Dis"},{"key":"1827_CR40","doi-asserted-by":"publisher","unstructured":"Xu M, Xu X, Li J, Li F (2019) Association between gut microbiota and autism spectrum disorder: a systematic review and meta-analysis. Front Psychiatry 10. https:\/\/doi.org\/10.3389\/fpsyt.2019.00473","DOI":"10.3389\/fpsyt.2019.00473"},{"key":"1827_CR41","doi-asserted-by":"publisher","first-page":"e00817","DOI":"10.1128\/msystems.00817-24","volume":"10","author":"Y Yang","year":"2024","unstructured":"Yang Y, Gao W, Zhu R et al (2024) Systematic identification of secondary bile acid production genes in global microbiome. mSystems 10:e00817\u2013e00824. https:\/\/doi.org\/10.1128\/msystems.00817-24","journal-title":"mSystems"},{"key":"1827_CR43","doi-asserted-by":"publisher","first-page":"108493","DOI":"10.1016\/j.ymgme.2024.108493","volume":"142","author":"T Zubarioglu","year":"2024","unstructured":"Zubarioglu T, K\u0131yk\u0131m E, K\u00f6se E et al (2024) Clinical, biochemical, and molecular insights into Cerebrotendinous Xanthomatosis: A nationwide study of 100 Turkish individuals. Mol Genet Metab 142:108493. https:\/\/doi.org\/10.1016\/j.ymgme.2024.108493","journal-title":"Mol Genet Metab"},{"key":"1827_CR42","doi-asserted-by":"publisher","first-page":"e70069","DOI":"10.1002\/jimd.70069","volume":"48","author":"T Zubarioglu","year":"2025","unstructured":"Zubarioglu T, Kad\u0131o\u011flu-Y\u0131lmaz B, K\u00f6se E et al (2025) Long-term outcomes of chenodeoxycholic acid therapy for cerebrotendinous xanthomatosis: a nationwide study on prognostic factors and treatment response. J Inherit Metab Dis 48:e70069. https:\/\/doi.org\/10.1002\/jimd.70069","journal-title":"J Inherit Metab Dis"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01827-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-01827-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01827-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:23:17Z","timestamp":1781641397000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-026-01827-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1827"],"URL":"https:\/\/doi.org\/10.1007\/s11011-026-01827-7","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"6 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from patients or their parents who served as subjects of the investigation. This study has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. Ethical approval for the study was obtained from the local ethics committee (approval number: E-22686390- 050.01.04-11880).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Consent for publication was obtained from all participants or their legal representatives.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"ChatGPT was used as an English proofreading service.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Use of AI and AI-assisted Technologies Statement"}}],"article-number":"60"}}